Overview Financials News + Filings Key Docs Ownership Insiders
|
|
Dermata Therapeutics, Inc.
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| | 10-K | 10-K | S-1 |
| Revenues | 100.0% | | 100.0% |
| Cost of goods sold | 100.0% | | 99.3% |
| Gross profit | 0.0% | | 0.7% |
| Research and development | 1917.2% | | 58.3% |
| General and administrative | 2437.2% | | 41.0% |
| Depreciation | | | 0.0% |
| EBIT | -4354.4% | | -99.3% |
| Pre-tax income | -4379.7% | | -104.8% |
| Income taxes | 0.0% | | 0.0% |
| Net income | -5799.7% | | -104.8% |
|